Biogen
BIIB
BIIB
920 hedge funds and large institutions have $24.7B invested in Biogen in 2022 Q2 according to their latest regulatory filings, with 78 funds opening new positions, 294 increasing their positions, 350 reducing their positions, and 94 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
920
Holders Change
-25
Holders Change %
-2.65%
% of All Funds
15.56%
Holding in Top 10
13
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+8.33%
% of All Funds
0.22%
New
78
Increased
294
Reduced
350
Closed
94
Calls
$974M
Puts
$1.03B
Net Calls
-$55.5M
Net Calls Change
-$46.2M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$130M |
| 2 |
Renaissance Technologies
New York
|
+$102M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$89.4M |
| 4 |
Morgan Stanley
New York
|
+$85.9M |
| 5 |
D.E. Shaw & Co
New York
|
+$73.8M |
Top Sellers
| 1 |
SAM
Southeastern Asset Management
Memphis,
Tennessee
|
-$178M |
| 2 |
Man Group
London,
United Kingdom
|
-$173M |
| 3 |
ClearBridge Investments
New York
|
-$111M |
| 4 |
American Century Companies
Kansas City,
Missouri
|
-$92.1M |
| 5 |
Two Sigma Investments
New York
|
-$85.4M |
